Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Shares Outstanding (2018 - 2026)

Alector's (ALEC) quarterly Shares Outstanding (Entity) came in at $111.7 million in Q2 2026, up 10.32% year-over-year from $101.2 million in Q2 2025, and up 0.57% quarter-over-quarter from $111.0 million in Q1 2026.

Analysis

Alector (ALEC) Shares Outstanding (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Shares Outstanding (Entity) for 9 consecutive years, with $111.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 10.32% year-over-year to $111.7 million in Q2 2026; TTM through Jun 2026 was $111.7 million, a 10.32% increase from a year earlier, with the FY2025 full-year figure at $110.4 million, up 11.38% from the prior year.
  • Shares Outstanding (Entity) was $111.7 million for Q2 2026 at Alector, up from $111.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $111.7 million in Q2 2026 and troughed at $82.0 million in Q1 2022.
  • A 5-year average of $94.3 million and a median of $96.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) advanced 1.11% in 2022 and climbed 16.74% in 2024, its largest moves.
  • Over 5 years, Shares Outstanding (Entity) stood at $82.9 million in 2022, then climbed by 2.39% to $84.9 million in 2023, then grew by 16.74% to $99.1 million in 2024, then gained by 11.38% to $110.4 million in 2025, then rose by 1.17% to $111.7 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $111.7 million (Q2 2026), $111.0 million (Q1 2026), and $110.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 61.30 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 133.61 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 147.70 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 217.35 Mn
10 Alector 274.68 Mn 101.88 Mn - 111.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 111.22 Mn
Mar 31, 2026 110.59 Mn
Dec 31, 2025 103.00 Mn
Sep 30, 2025 102.60 Mn
Jun 30, 2025 100.37 Mn
Mar 31, 2025 99.40 Mn
Dec 31, 2024 96.59 Mn
Sep 30, 2024 97.52 Mn
Jun 30, 2024 96.67 Mn
Mar 31, 2024 93.81 Mn
Dec 31, 2023 83.73 Mn
Sep 30, 2023 83.93 Mn
Jun 30, 2023 83.50 Mn
Mar 31, 2023 83.10 Mn
Dec 31, 2022 82.47 Mn
Sep 30, 2022 82.60 Mn
Jun 30, 2022 82.39 Mn
Mar 31, 2022 82.10 Mn
Dec 31, 2021 80.42 Mn
Sep 30, 2021 80.96 Mn